However, we for the first time showed that mice administered Mdivi-1 revealed a significant decrease in expression of Tm6sf2. This suggests that Tm6sf2 is involved in fat accumulation in NASH and that targeting Tm6sf2 is important for improving lipid metabolism and suppressing fat accumulation in NASH. Here, TM6SF2 is linked to metabolic dysfunction-associated steatohepatitis.